NCT01642745
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,975 public trials
742 recruiting studies
Lung Diseases, Obstructive trial results
Completed
RELOVAIR® Lung Deflation Study
NCT01691885
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site London, United Kingdom
NCT01354782
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Nycomed Investigational Site Beijing, China
NCT02264691
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of Texas Medical Branch Galveston, Texas, United States
Completed
Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)
NCT02853838
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis, Viral, +7 more
- Locations
-
- Hospital Padre Hurtado Santiago, Santiago Metropolitan, Chile
NCT00108823
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, COPD, Disease Attributes, +6 more
- Locations
-
- ALTANA Pharma Cities in California, California, United States
- ALTANA Pharma Cities in Colorado, Colorado, United States
- ALTANA Pharma Cities in Florida, Florida, United States
- ALTANA Pharma Cities in Missouri, Missouri, United States
NCT00242294
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Nycomed Japan and Mitsubishi Tanabe Oharma Corporation Osaka, Japan
NCT00246935
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Nycomed in Japan and Mitsubishi Tanabe Pharma Corporation Osaka, Japan
NCT01943552
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 244.2514.86008 Boehringer Ingelheim Investigational Site Chengdu, China
- 244.2514.86006 Boehringer Ingelheim Investigational Site Guangzhou, China
- 244.2514.86007 Boehringer Ingelheim Investigational Site Guangzhou, China
- 244.2514.86010 Boehringer Ingelheim Investigational Site Guangzhou, China
NCT00163475
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- ALTANA Pharma Cities in Australia, Australia
- ALTANA Pharma Cities in Belgium, Belgium
- ALTANA Pharma Cities in France, France
- ALTANA Pharma Cities in South Africa, South Africa